Literature DB >> 16906402

Prediction of cervical involvement in endometrial cancer by hysteroscopy.

Benny Almog1, Guy Gutman, Joseph B Lessing, Dan Grisaru.   

Abstract

OBJECTIVE: This study evaluated the ability of hysteroscopy to preoperatively predict cervical involvement in endometrial cancer.
METHODS: The records of 110 surgically staged consecutive endometrial cancer patients treated at our institution from 1997 to 2003 were retrospectively analyzed. Data on demographics, preoperative staging procedures, surgical pathology reports, and adjuvant treatments were retrieved.
RESULTS: Fourteen (12.7%) patients had cervical involvement (stage II) according to the surgical pathology report, of whom nine (8.1%) had stage IIA and five (4.6%) had stage IIB. Clinical evaluation by speculoscopy and palpation had failed to reveal any indication of cervical involvement. Preoperative diagnostic hysteroscopy procedures were included. None of the hysteroscopy procedures revealed any suspicious lesion in the cervical canal.
CONCLUSION: Hysteroscopy and clinical examination fail to adequately predict cervical involvement in endometrial carcinoma. Fractional D&C appears to be the best method until a more effective alternative becomes available.

Entities:  

Mesh:

Year:  2006        PMID: 16906402     DOI: 10.1007/s00404-006-0220-5

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Endometrial adenocarcinoma in a 27-year-old woman.

Authors:  Anis Fadhlaoui; Jamel Ben Hassouna; Mohamed Khrouf; Fethi Zhioua; Anis Chaker
Journal:  Clin Med Insights Case Rep       Date:  2010-08-12

2.  Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma.

Authors:  Dan Wang; Jia-Xin Yang; Dong-Yan Cao; Xi-Run Wan; Feng-Zhi Feng; Hui-Fang Huang; Keng Shen; Yang Xiang
Journal:  Onco Targets Ther       Date:  2013-03-16       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.